No. of Recommendations: 10
Several observers have pointed out that the USSC most definitely did not "approve" of mifepristone and/or misoprostol. The ruling specifically cited the standing of the plaintiff as the cause for overturning the court's ruling from the fringe district in Texas. If court followers are to be believe, John Roberts has been consistently annoyed by the pattern of District Courts accepting highly suspect cases and imposing NATIONWIDE bans on various processes, products, drugs, etc. as a means of legislating through the courts. Never mind the USSC does the same thing on issues its conservative majority was paid considerably to care about, like abortion, business regulation, civil rights, etc.
While access to these drugs remains unchanged for now, this ruling served to clarify to future plaintiffs EXACTLY how they should frame the next case aimed at blocking the sale and use of these drugs. It did not confirm the right to access for such drugs, even in cases to protect the welfare of the mother in cases with unviable fetuses.
This issue will be back. I would guess in under 3 years.
WTH
